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Purpose or Objective: Surgical implant fixation is a common 
technique in case of spinal and paraspinal tumors, usually 
considered good candidates for particle therapy 
(PT).Traditional orthopedic metal implants significantly differ 
from normal tissues in terms of density and composition, 
leading to substantial perturbation effects on radiation 
beams. Recently a Carbon Fibers Reinforced(CFR)-PEEK 
stabilization device completely metal free has become 
available (CarboFix Orthopedics). This device is supposed to 
be more suitable for PT where treatment accuracy can be 
highly compromised by uncertainties in particles range. The 
aim of this study was to investigate and compare 
uncertainties related to the use of titanium and CFR-PEEK 
screws in terms of image quality, reconstruction artifacts, 
contouring and dose calculation accuracy, for both proton 
and carbon ion beams. 
 
Material and Methods: Two vertebral body models, hosting 
two different types of orthopedic implants (a titanium and a 
CFR-PEEK implant), were positioned inside a water phantom 
to simulate real patients configuration. A CT scan was 
acquired according to our clinical protocols to evaluate 
induced HU artifacts and their impact on contouring 
uncertainties. Titanium and CFR-PEEK water equivalent path 
lengths (WEPL) were measured and implemented in our 
treatment planning systems (TPS). Implants and artifacts 
were contoured for proper material density assignment in the 
TPS HU to WEPL calibration curve. Plans were optimized for 
both proton and carbon ions, with and without HU correction, 
to evaluate the impact of CT artefacts and contouring 
uncertainties on dosimetric calculation accuracy, in 
comparison with MC simulations. Two patient cases, 
previously treated in our center were analyzed in terms of 
target and OAR dose deviation due to wrong material 
assignment, with respect to the clinically approved plan. 
 
Results: CFR-PEEK implants did not cause appreciable HU 
artifacts on CT images compared to titanium ones. Significant 
differences in dose distribution between TPS and MC 
simulations in high-Z region were observed, while a good 
agreement was found for CFR-PEEK screws. Inaccurate 
material assignment did not significantly vary the clinical 
case 3D dose distribution for CFR-PEEK implants (<1%). 
Titanium screws made difficult to correctly contour both 
targets and OARs. Moreover, local dose deviations up to 20% 
can be find when HU uncertainties are not correctly 
managed. Besides efforts made towards a robust optimization 
with respect to potential beam perturbation, dose delivered 
to healthy tissues positioned behind targets along the implant 
trajectory can be substantially altered. 
 
Conclusion: CFR-PEEK stabilization devices are more suitable 
than commonly-used titanium devices for PT of patients with 
orthopedic implants, leading to less image alteration and 
consequently reduced contouring uncertainties together with 
a significantly higher dosimetric treatment planning 
accuracy. 
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Purpose or Objective: To compare dosimetry plans using a 
commercially model based dose calculation algorithm 
(MBDCA) following TG186 recommendations, and the 
conventional TG43 method in an 192Ir high dose rate (HDR) 
brachytherapy (BT) procedure for the treatment of skin 
lesions. 
 
Material and Methods: Plesiotherapy treatment was 
performed in three patients with lesions localized in the pre 
auricular region (patient 1), the nasal dorsum (patient 2) and 
the nasal tip (patient 3). The lesions (PTV) were marked with 
radiopaque markers. Patients were immobilized with a 
thermoplastic mask. A bolus slab of 2 mm thickness and 
plastic catheters were applied over the mask, and the whole 
set was fixed with two bolus slabs. All dosimetries plans were 
based on a CT with 1,25mm slices thickness and the dose was 
delivered with a micro-Selectron afterloader. Treatment 
plans were performed using both the TG43 and TG186 dose 
calculation methods of the Oncentra Brachy v4.5 treatment 
planning system (TPS). Analysis included dose to the OARs 
(lens, ocullar globe and optic nerves) and to the prescription 
points (3 mm tissue depth). The TG186 results were obtained 
using the standard accuracy level option of model-based 
algorithm (Oncentra Brachy-Advanced Collapsed cone Engine 
(ACE), Elekta), resulting in calculation times between 7 – 10 
min. 
 
Results: In all cases, TG 43 overestimated the doses in the 
prescription points and in the OARs, in the range of 3.0% and 
6.2%, respectively (Figure 1). 
 
 
 
Conclusion: Although differences were found between the 
dosimetrie plans obtained with the TG43 and model based 
dose calculation algorithm following TG186 
recommendations, they are minor in terms of prescription 
dose points for skin lesions, since a 5% difference is within 
clinical tolerances in brachytherapy. 
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Purpose or Objective: At the introduction of RapidArc (RA) 
technique, the paper by Ling et al 2008 has constituted a 
reference, proposing RA commissioning machine quality 
assurance (QA) tests. Thanks to the free availability, many 
centers have implemented these tests in their periodic QA. 
Recently, tests identified as T2 (variation of dose rate DR and 
